NAVO:J School-Based Group Intervention for Adolescent Mental Health

June 19, 2026 updated by: Chang Hyung Hong, Ajou University School of Medicine

Effects of a School-Based Group Intervention Using the Digital Mental Health Platform NAVO:J on Adolescent Mental Health

The purpose of this study is to determine and verify whether a school-based group intervention using the digital mental health platform NAVO:J can effectively improve the mental health of adolescents-particularly reducing depression, anxiety, and stress while enhancing resilience.

Study Overview

Status

Not yet recruiting

Conditions

Detailed Description

NAVO:J is a digital mental health platform designed to promote adolescent mental health.

The intervention will be conducted as a single-group pre-post design with students (N = 250 subjects) who apply for the Level 2-2 (group intervention) program.

The intervention period will be 17 weeks (17 sessions, once a week for about 40 minutes), with a mid-point evaluation at week 8 and a post-intervention evaluation at week 17.

Study Type

Interventional

Enrollment (Estimated)

250

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Suwon, South Korea, 16499
        • Ajou Medical University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Students who apply for the group intervention program
  • Possession of an internet-enabled smartphone
  • Consent to study participation by both the participant and their legal guardian

Exclusion Criteria:

  • Inability to install or run "NAVO:J" on the participant's smartphone
  • Current participation in another interventional study
  • A medical condition severe enough to preclude the intervention or outcome assessment
  • Judged by the researcher to be unlikely to participate cooperatively through the end of the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: NAVO:J Intervention Group
Participants in this single-arm group use the digital mental health platform NAVO:J for 17 weeks (17 sessions, once a week for approximately 40 minutes). Each session includes app-based activities such as recommended mental health videos, tailored self-care solutions, self-assessments, mind coaching, and diary entries. Mental health outcomes are assessed at baseline, mid-point (week 8), and post-intervention (week 17) using a single-group pre-post design.
Participants use NAVO:J, a digital mental health platform developed for adolescents, delivered as a structured group intervention over 17 weeks (17 sessions, once weekly, approximately 40 minutes each). The platform provides algorithm-based recommended videos, 12 tailored "mind solutions" based on emotional-behavioral characteristics, self-assessments (personality, depression, anxiety, stress, self-esteem, smartphone use), expert-supported community features, mind coaching, growth tracking across 10 adolescent mental health indicators, and a mood diary. Sessions are facilitated weekly by trained researchers following a standardized manual.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Depression (PHQ-9)
Time Frame: Baseline, week 8 (mid-point), week 17 (post-intervention)
Depression is measured using the Korean version of the Patient Health Questionnaire-9 (PHQ-9), based on the DSM-IV criteria for major depressive disorder, assessing symptoms experienced over the past two weeks. The scale consists of 9 items rated on a 4-point Likert scale (score range: 0-27). Higher scores indicate more severe depressive symptoms. Change is assessed by comparing scores at baseline, mid-point, and post-intervention.
Baseline, week 8 (mid-point), week 17 (post-intervention)
Change in Resilience (CD-RISC-10)
Time Frame: Baseline, week 8 (mid-point), week 17 (post-intervention)
Resilience is measured using the 10-item Connor-Davidson Resilience Scale (CD-RISC-10), a self-report measure of an individual's ability to recover and adapt under adversity or stress. Each item is rated on a 5-point Likert scale (score range: 0-40). Higher scores indicate greater resilience. Change is assessed by comparing scores at baseline, mid-point, and post-intervention.
Baseline, week 8 (mid-point), week 17 (post-intervention)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Maum-EASY Anxiety and Depression Problems
Time Frame: Baseline, week 8 (mid-point), week 17 (post-intervention)
The Maum-EASY Test is a self-report screening tool developed to detect students' mental health problems early and prevent worsening. The anxiety and depression subscale measures the level of anxiety- and depression-related problems, with each item rated on a 4-point Likert scale (0-3). Higher scores indicate a greater likelihood of such problems (score range: 0-24). Change is assessed by comparing scores at baseline, mid-point, and post-intervention.
Baseline, week 8 (mid-point), week 17 (post-intervention)
Change in Maum-EASY Suicide and Crisis Problems
Time Frame: Baseline, week 8 (mid-point), week 17 (post-intervention)
The suicide and crisis subscale of the Maum-EASY Test measures the level of serious risk symptoms such as suicidality and severe psychological problems, with each item rated on a 4-point Likert scale (0-3). Higher scores indicate a greater need for priority attention and intervention (score range: 0-18). Change is assessed by comparing scores at baseline, mid-point, and post-intervention.
Baseline, week 8 (mid-point), week 17 (post-intervention)
Change in Maum-EASY Externalizing Problems
Time Frame: Baseline, week 8 (mid-point), week 17 (post-intervention)
The externalizing subscale of the Maum-EASY Test measures the level of outwardly expressed behavioral problems, with each item rated on a 4-point Likert scale (0-3). Higher scores indicate a greater likelihood of problems such as oppositional behavior, delinquency, and habitual lying (score range: 0-24). Change is assessed by comparing scores at baseline, mid-point, and post-intervention.
Baseline, week 8 (mid-point), week 17 (post-intervention)
Change in Maum-EASY Psychological Trauma Problems
Time Frame: Baseline, week 8 (mid-point), week 17 (post-intervention)
The psychological trauma subscale of the Maum-EASY Test measures the presence of traumatic experiences and related problems, with each item rated on a 4-point Likert scale (0-3). Higher scores indicate a greater likelihood of problems such as intrusive memories, avoidance of others, and distrust of others (score range: 0-21). Change is assessed by comparing scores at baseline, mid-point, and post-intervention.
Baseline, week 8 (mid-point), week 17 (post-intervention)
Change in Maum-EASY School Life Adjustment
Time Frame: Baseline, week 8 (mid-point), week 17 (post-intervention)
The school life adjustment subscale of the Maum-EASY Test measures difficulties related to school adjustment and reduced coping skills, with each item rated on a 4-point Likert scale (0-3). Higher scores indicate a greater likelihood of problems such as lack of confidence, maladaptive coping, and difficulty making friends (score range: 0-21). Change is assessed by comparing scores at baseline, mid-point, and post-intervention.
Baseline, week 8 (mid-point), week 17 (post-intervention)
Change in Subjective Mental Health (VAS)
Time Frame: Baseline, week 8 (mid-point), week 17 (post-intervention)
Subjective mental health is measured using a self-report Visual Analog Scale (VAS) developed by the research team to multidimensionally assess adolescents' perceived mental health. It consists of 9 items, each rated on an 11-point scale from 0 (not at all) to 10 (very much). It is used as a supplementary measure of overall perceived mental health. Change is assessed by comparing scores at baseline, mid-point, and post-intervention.
Baseline, week 8 (mid-point), week 17 (post-intervention)
Change in Empathy Quotient (K-EQ)
Time Frame: Baseline, week 8 (mid-point), week 17 (post-intervention)
Empathy is measured using the Korean version of the Empathy Quotient (K-EQ), which assesses multidimensional empathic ability across cognitive empathy, emotional empathy, and social skills. It consists of 17 items rated on a 4-point Likert scale (score range: 17-68). Higher scores indicate greater empathic ability. Change is assessed by comparing scores at baseline, mid-point, and post-intervention.
Baseline, week 8 (mid-point), week 17 (post-intervention)
Change in Grit (GRIT-S)
Time Frame: Baseline, week 8 (mid-point), week 17 (post-intervention)
Grit is measured using the Short Grit Scale (GRIT-S), comprising two subfactors: consistency of effort and consistency of interest. It consists of 8 items rated on a 5-point Likert scale (score range: 6-30). Higher scores indicate greater grit. Change is assessed by comparing scores at baseline, mid-point, and post-intervention.
Baseline, week 8 (mid-point), week 17 (post-intervention)

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Big Five Personality Traits (BFI-K-10)
Time Frame: Baseline, week 8 (mid-point), week 17 (post-intervention)
Personality is measured using a 15-item short form of the Big Five Inventory, comprising five subfactors: neuroticism, extraversion, openness, agreeableness, and conscientiousness. Each item is rated on a 5-point Likert scale from 1 (strongly disagree) to 5 (strongly agree) (score range: 15-75). Change is assessed by comparing scores at baseline, mid-point, and post-intervention.
Baseline, week 8 (mid-point), week 17 (post-intervention)
NAVO:J App Log Data (Adherence)
Time Frame: Throughout the intervention period (week 1 to week 17)
Objective adherence is assessed using NAVO:J platform log data, including app access time and the scope of activities completed during the study period. This measure is used to verify participant compliance with the intervention.
Throughout the intervention period (week 1 to week 17)
Self-Reported Adherence Questionnaire
Time Frame: Week 17 (post-intervention)
Subjective adherence is assessed using a self-report questionnaire on the number and duration of app sessions during the study period, administered at the post-intervention assessment.
Week 17 (post-intervention)
Smartphone App Satisfaction Questionnaire
Time Frame: Week 17 (post-intervention)
App satisfaction is assessed using a self-report questionnaire evaluating ease of use, information reliability and quality, perceived improvement in mental health, and overall satisfaction, administered at the post-intervention assessment.
Week 17 (post-intervention)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Chang Hyung Hong, Ajou Medical Center

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

June 24, 2026

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

May 1, 2027

Study Registration Dates

First Submitted

June 19, 2026

First Submitted That Met QC Criteria

June 19, 2026

First Posted (Actual)

June 24, 2026

Study Record Updates

Last Update Posted (Actual)

June 24, 2026

Last Update Submitted That Met QC Criteria

June 19, 2026

Last Verified

June 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • AJOUIRB-IV-2026-290

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Depression

Clinical Trials on NAVO:J (digital mental health platform)

3
Subscribe